Symmetric dimethylarginine concentrations in healthy neonatal foals and mares

Background Symmetric dimethylarginine (SDMA) is a renal biomarker correlated with glomerular filtration rate (GFR). Objectives Describe changes in SDMA in clinically healthy foals and their mares during the first month postfoaling. Animals Convenience sampling of healthy periparturient Thoroughbred mares and their full-term foals from a population of client-owned horses. Methods Serum and EDTA whole blood samples were collected from mares in their last month of pregnancy and then from mares and foals at approximately <12 hours, 48 hours, 7 days, and 30 days postbirth. Samples were processed at a commercial reference laboratory for CBC and serum biochemistry, including SDMA concentrations. Results A total of 125 foals and 104 mares were included. Upper limits for SDMA concentrations in foals were above the adult horse reference interval for the first 20 or more days of life. Median SDMA concentrations decreased from 70 mu g/dL (range, 7-100 mu g/dL) to 18 mu g/dL (range, 6-27 mu g/dL) during the first 3 to 4 weeks of life. At birth, the SDMA concentration reference range was established as 0 to 100 mu g/dL (upper limit of the assay); 0 to 85 mu g/dL for 1 to 4 days old, 0 to 36 mu g/dL for 5 to 10 days old, and 0 to 24 mu g/dL for 20 to 30 days old. The upper reference limits for SDMA concentrations in mares did not differ from the general reference interval for adult horses. No correlation was identified between mare and foal SDMA concentrations (rho = .06, P = .58). Conclusions and Clinical Importance Foal SDMA concentrations remained higher than the upper limit of the adult reference range and foals require a different reference range dependent on age.